Using the ALBA® device to improve arm function in adults with brain injuries
"Evaluation Of ALBA® Device for Upper Extremity Motor Function In Adults (18-80 Years Old) With Hemiparesis Secondary To Acquired Brain Injury In Subacute And Chronic Phases"
NA · uMov · NCT05824416
This study is testing if using the ALBA® device along with regular therapy can help adults with brain injuries improve their arm function better than just regular therapy alone.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 32 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | uMov (industry) |
| Locations | 1 site (Santiago, Av. Laguna Sur 6561 Estación Central) |
| Trial ID | NCT05824416 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of the ALBA® device in enhancing upper extremity motor function in adults with hemiparesis due to acquired brain injuries. Participants will be randomly assigned to either a control group receiving conventional therapy or an experimental group that combines conventional therapy with ALBA® training. The training consists of 45 minutes of therapy, five days a week, over four weeks, with assessments conducted before, after, and three months post-intervention. The study aims to determine if the addition of robotic training can lead to better rehabilitation outcomes compared to standard treatment alone.
Who should consider this trial
Good fit: Ideal candidates include adults with hemiparesis due to an acquired brain injury who can understand and follow instructions.
Not a fit: Patients with severe cognitive or physical impairments that prevent them from participating in the training may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve motor function and rehabilitation outcomes for patients with upper extremity disabilities following brain injuries.
How similar studies have performed: Previous studies have shown promising results with robotic-assisted rehabilitation techniques, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients of Los Coihues clinic Diagnosis of acquired brain injury. Cognitive capacity and language that allows understanding and following the therapist's instructions. Trunk control. Subacute and chronic stage (up to 2 years post injury). Upper extremity paresis able to perform movements with eliminated gravity (modified MRC 2). Exclusion Criteria: Cardiovascular instability Visual or acoustic limitations. Severe hypertonia (≥3 Ashworth Scale). Upper extremity with passive joint limitation and/or traumatic injury. Neuropsychological alteration (global aphasia, severe attentional deficit, spatial perception alteration). Moderate to severe cognitive-behavioral alterations that do not allow the understanding of instructions. Severe alterations of consciousness. Deficit in cephalic control. Severe deficit in sedentary balance.
Where this trial is running
Santiago, Av. Laguna Sur 6561 Estación Central
- Clínica Los Coihues — Santiago, Av. Laguna Sur 6561 Estación Central, Chile (RECRUITING)
Study contacts
- Study coordinator: Pamela A Salazar, Ing
- Email: pamela@umov.cl
- Phone: +56926444880
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke, Acquired Brain Injury, Adults